Trial Profile
Trastuzumab treatment of early breast cancer: Long-term results from a prospective observation study, including a large cohort of elderly patients
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2018
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Antineoplastics
- Indications Early breast cancer
- Focus Therapeutic Use
- 01 Sep 2014 New trial record